BENDAMUSTINE HYDROCHLORIDE | N212209 | AZURITY PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2025-01-17 | Active | — | |
| D. Del. | 2024-01-17 | Active | — | |
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC et al 7 patentsBendamustine Hydrochloride | D. Del. | 2021-08-31 | Terminated 2022-10-25 | — |
| D. Del. | 2018-12-11 | Terminated 2019-05-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).